- Home
- SATL vs CTKB Comparison
SATL vs CTKB Comparison
Compare SATL & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SATL
- CTKB
- Stock Information
- Founded
- SATL 2010
- CTKB 1990
- Country
- SATL United States
- CTKB United States
- Employees
- SATL N/A
- CTKB N/A
- Industry
- SATL Radio And Television Broadcasting And Communications Equipment
- CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SATL Technology
- CTKB Health Care
- Exchange
- SATL Nasdaq
- CTKB Nasdaq
- Market Cap
- SATL 433.8M
- CTKB 430.6M
- IPO Year
- SATL N/A
- CTKB 2021
- Fundamental
- Price
- SATL $3.56
- CTKB $3.69
- Analyst Decision
- SATL
- CTKB Hold
- Analyst Count
- SATL 0
- CTKB 4
- Target Price
- SATL N/A
- CTKB $6.00
- AVG Volume (30 Days)
- SATL 1.7M
- CTKB 960.6K
- Earning Date
- SATL 08-14-2025
- CTKB 08-05-2025
- Dividend Yield
- SATL N/A
- CTKB N/A
- EPS Growth
- SATL N/A
- CTKB N/A
- EPS
- SATL N/A
- CTKB N/A
- Revenue
- SATL $12,929,000.00
- CTKB $197,050,000.00
- Revenue This Year
- SATL N/A
- CTKB $0.91
- Revenue Next Year
- SATL N/A
- CTKB $7.75
- P/E Ratio
- SATL N/A
- CTKB N/A
- Revenue Growth
- SATL 9.47
- CTKB N/A
- 52 Week Low
- SATL $0.72
- CTKB $2.37
- 52 Week High
- SATL $5.49
- CTKB $7.63
- Technical
- Relative Strength Index (RSI)
- SATL 50.65
- CTKB 60.88
- Support Level
- SATL $3.39
- CTKB $3.20
- Resistance Level
- SATL $3.77
- CTKB $3.44
- Average True Range (ATR)
- SATL 0.22
- CTKB 0.18
- MACD
- SATL 0.02
- CTKB 0.01
- Stochastic Oscillator
- SATL 50.00
- CTKB 96.77
About SATL Satellogic Inc.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.
About CTKB Cytek Biosciences Inc.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.